Advinus Therapeutics, a Tata group enterprise on Thursday said it has forged an alliance with Corning India, a move which would help the company in new drug development and generate revenues up to USD 2 million in the first year of operations.
“We are expecting USD 1-2 million in first year of operations (2011-12) from leveraging Corning Epic technology,” Advinus CEO and MD Rashmi H. Barbhaiya told reporters here.
Tata Group promoted Advinus Therapeutics and Corning India today announced the collaboration to bring Corning’s Epic label-free detection technology to India.
The alliance between Advinus and Corning enables Advinus to leverage the Corning Epic technology to enhance its own drug discovery capabilities and to provide services to companies both in India and abroad, the company said.
Corning’s Epic technology combines biochemical detection and cellular analysis on a single label free platform to enable a wide range of research applications, it said.
The technology helps identify targets, pathways and interactions providing more biologically relevant data to the drug discovery process, it added.
“This collaboration is in line with Corning’s strategy of bringing innovative technology to India through collaborations with leading Indian companies,” Corning India President Rustom Desai said.
US-based Corning Incorporated is the world leader in specialty glass and ceramics. It operates in India through its Gurgaon-based branch office.
